e-learning
resources
Munich 2014
Tuesday, 09.09.2014
E-cigarettes in different populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice.
P. Geraghty, J. Dabo, I. Garcia-Arcos, N. Cummins, R. Foronjy (New York, United States Of America)
Source:
International Congress 2014 – E-cigarettes in different populations
Session:
E-cigarettes in different populations
Session type:
Oral Presentation
Number:
3435
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Geraghty, J. Dabo, I. Garcia-Arcos, N. Cummins, R. Foronjy (New York, United States Of America). LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice.. Eur Respir J 2014; 44: Suppl. 58, 3435
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
LATE-BREAKING ABSTRACT: Short-term, conditional TGFá expression produces airway smooth muscle thickening and hyperresponsiveness in mice deficient in early growth response one
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Acute cigarette smoke induces accelerated emphysema development in bENaC-overexpressed mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
Immunoaging augments sensitivity to cigarette smoke-induced COPD
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
LATE-BREAKING ABSTRACT: The effects of NKT cells on the different degrees of severity bronchial asthma in mice
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept